Live Breaking News & Updates on Addex Therapeutic Annual Report

Stay updated with breaking news from Addex therapeutic annual report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024

Geneva, Switzerland, May 31, 2024 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological. ....

United States , Mikhail Kalinichev , Tim Dyer , Mike Sinclair , Swiss Exchange , Janssen Pharmaceuticals Inc , Translational Science , Addex Therapeutics , Conference Call , Participant Dial In , American Depositary Shares , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutic ,

Addex to Present at Bio€quity Europe 2024

Addex to Present at Bio€quity Europe 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Tim Dyer , Mike Sinclair , Swiss Exchange , Janssen Pharmaceuticals Inc , Kursaal Congress Center , San Sebasti , Monday May , American Depositary Shares , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutics , Addex Therapeutic ,

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2024 - Addex Therapeutics , a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small. ....

United States , Tim Dyer , Roger Mills , Mike Sinclair , Swiss Exchange , Janssen Pharmaceuticals Inc , Chief Medical Officer , Janssen Pharmaceuticals , American Depositary Shares , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutics , Addex Therapeutic ,

Addex to Present at the Swiss Biotech Day 2024

Geneva, Switzerland, April 19, 2024 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will. ....

United States , Mike Sinclair , Tim Dyer , Janssen Pharmaceuticals Inc , Congress Center , Swiss Exchange , Swiss Biotech Day , Addex Therapeutics , Janssen Pharmaceuticals , American Depositary Shares , Executive Officer , Halsin Partners , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutic ,

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024

Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Tim Dyer , Mike Sinclair , Mikhail Kalinichev , Swiss Exchange , Janssen Pharmaceuticals Inc , Release Full Year , Host Conference Call , Addex Therapeutics , Translational Science , Conference Call , Participant Dial In , Janssen Pharmaceuticals , American Depositary Shares , Executive Officer , Halsin Partners , Forward Looking Statements , Private Securities Litigation Reform Act , Addex Therapeutic Annual Report , Addex Therapeutic ,